Whereas, CRP has been considered a potential therapeutic target for inflammatory diseases, including infections, since CRP bound to a multivalent ligand can efficiently initiate the assembly of a C3 convertase through the classical pathway and thus decorate the surface of the ligand with opsonic complement fragments (6, 15, 16). This evidence concerns the gene CRP and infection.